Rapport Therapeutics, Inc.

NASDAQ
RAPP
Stock
Yield per half year: -30.63%
Dividend yield: 0%
Sector: Healthcare

Reporting Rapport Therapeutics, Inc.

Capitalization

IFRS
Reporting Annual Quarterly
2022 2023 2024 LTM 5 year average CAGR 5
Чистая прибыль, млрд $
-0.0107 -0.0348 -0.0783 -0.0783 -0.0413 94.14
EV, млрд $
-0.0312 -0.068 3.62 3.62 1.17 -587.74
EBIT, млрд $
-0.0104 -0.0348 -0.0783 -0.0783 -0.0412 95.99
EBITDA, млрд $
-0.0104 -0.0347 -0.0775 -0.0775 -0.0409 95.32
OIBDA, млрд $
-0.0101 -0.0361 -0.0822 -0.0822 -0.0428 101.15
Баланс стоимость, млрд $
0.0195 0.1409 0.3054 0.3054 0.1553 150.19
FCF, млрд $
-0.0035 -0.0288 -0.0672 -0.0672 -0.0332 167.77
Операционный денежный поток, млрд $
-0.0032 -0.0272 -0.0648 -0.0648 -0.0317 172.57
Операционная прибыль, млрд $
-0.0104 -0.0362 -0.0831 -0.0831 -0.0432 99.92
Операционные расходы, млрд $
0.0104 0.0361 0.0831 0.0831 0.0432 99.92
CAPEX, млрд $
0.000284 0.0016 0.0024 0.0024 0.0014 103.69


Balance sheet

IFRS
Reporting Annual Quarterly
2022 2023 2024 LTM 5 year average CAGR 5
Наличность, млрд $
0.0312 0.0702 0.0568 0.0568 0.0527 22.10
Short Term Investments $
0.0773 0.2485 0.2485 0.1629 79.30
Total Current Assets $
0.0313 0.1509 0.3098 0.3098 0.1640 114.71
Активы, млрд $
0.0316 0.1554 0.3149 0.3149 0.1673 115.19
Short Term Debt $
0.00067 0.000737 0.000737 0.0007 4.88
Задолженность, млрд $
0.0121 0.0145 0.0095 0.0095 0.0120 -7.75
Чистый долг, млрд $
-0.0312 -0.068 -0.0553 -0.0553 -0.0515 21.02
Долг, млрд $
0.0021 0.0015 0.0015 0.0018 -15.48
Interest income $
0.0025 0.0025 0.00
Расходы на обслуживание долга $
0.000285 0.0003 0.00
Чист. проц. доходы, млрд $
0.0025 0.0025 0.0025 0.00
Амортизация, млрд $
0.0000 0.000112 0.000839 0.000839 0.0005 173.70
Себестоимость, млрд $
0.0000 0.000112 0.000112 0.0001 0.00


Share

IFRS
Reporting Annual Quarterly
2022 2023 2024 2025 LTM 5 year average CAGR 5
EPS -0.2912 -0.1924 -0.3776 -0.3776 -0.2871 9.05
Цена акции ао 17.74 11.19 11.19 14.46 -20.58
Число акций ао, млн 36.58 180.79 207.38 207.38 141.58 78.31
FCF/акцию -0.0964 -0.1594 -0.3242 -0.3242 -0.1933 49.82


Efficiency

IFRS
Reporting Annual Quarterly
2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROE, % -54.61 -43.36 -35.09 -35.09 17.60 -44.3533 -13.71
ROA, % -33.71 -37.2 -33.3 -33.3 5.71 -34.7367 -0.41
ROS, % 0 0 0 13.36
ROCE, % -34.63 -23.72 -25.58 -25.64 -25.64 29.73 -27.3925 -7.24
Ebit margin, % 0 0 18.53
Рентаб EBITDA, % 0 0 26.10
Operation Margin, % 0 0 0 16.64


Coefficients

IFRS
Reporting Annual Quarterly
2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/BV
12.05 12.05 8.88 12.05 0.00
P/FCF
0 0 0 8.97
E/P
0 0 0 0.03
EV/EBIT
3.01 1.96 -46.27 -46.27 -46.27 88.62 -21.8925 -298.01
EV/EBITDA
3.01 1.96 -46.78 -46.78 53.93 -13.9367 -349.55
EV/S
0 0 0 8.39
EV/FCF
8.84 2.36 -53.9 -53.9 -53.9 21.66 -24.1500 -257.14
Debt/EBITDA
-0.0619 -0.0191 -0.0191 -0.0191 2.61 -0.0334 -32.43
Netdebt/Ebitda
3.01 1.96 0.7142 0.7142 0.7142 0.49 1.60 -30.21
Debt/Ratio
0.0138 0.0047 0.0047 0.0047 0.24 0.0077 -30.17
Debt/Equity
0.0152 0.0048 0.0311 0.0311 2.82 0.0170 26.95
Debt/Net Income
-0.0617 -0.0188 -0.0188 -0.0188 10.75 -0.0331 -32.71
PEG
0 0 -67.62
Бета
-0.7401 0.3742 0.3742 -0.68 -0.1830 -171.11
Индекс Альтмана
-0.5331 -0.4566 -0.4566 12.59 -0.4949 -7.45


Dividends

IFRS
Reporting Annual
LTM Industry average 5 year average CAGR 5
Дивиденд
0
Див доход, ао, %
0 1.71


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe